FR2457286A2 - 2,4-Di:substd.-pyrimidine-5-carboxamide derivs. - useful as neuroleptics for treating psychic disorders (BE 20.8.79) - Google Patents

2,4-Di:substd.-pyrimidine-5-carboxamide derivs. - useful as neuroleptics for treating psychic disorders (BE 20.8.79)

Info

Publication number
FR2457286A2
FR2457286A2 FR7902286A FR7902286A FR2457286A2 FR 2457286 A2 FR2457286 A2 FR 2457286A2 FR 7902286 A FR7902286 A FR 7902286A FR 7902286 A FR7902286 A FR 7902286A FR 2457286 A2 FR2457286 A2 FR 2457286A2
Authority
FR
France
Prior art keywords
och3
oet
neuroleptics
useful
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7902286A
Other languages
French (fr)
Other versions
FR2457286B2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Priority to FR7902286A priority Critical patent/FR2457286A2/en
Priority to GR58323A priority patent/GR66581B/el
Priority to US06/011,752 priority patent/US4250178A/en
Priority to IT20206/79A priority patent/IT1113438B/en
Priority to ES477852A priority patent/ES477852A1/en
Priority to CA321,796A priority patent/CA1096868A/en
Priority to LU80937A priority patent/LU80937A1/en
Priority to CH159879A priority patent/CH639078A5/en
Priority to JP1896279A priority patent/JPS54130585A/en
Priority to SE7901493A priority patent/SE446450B/en
Priority to DE19792906461 priority patent/DE2906461A1/en
Priority to AU44392/79A priority patent/AU526298B2/en
Priority to GB7905890A priority patent/GB2014984B/en
Priority to NL7901333A priority patent/NL7901333A/en
Publication of FR2457286A2 publication Critical patent/FR2457286A2/en
Application granted granted Critical
Publication of FR2457286B2 publication Critical patent/FR2457286B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pyrimidine derivs. of formula (I) are new. In (I) NR2R3 is (a) azcridimyl and R, R1=NH2, OCH3, (b) NH (CH2)2NR4R5, (c) U-Q'-pyrrolidin-3-yl)amino, Q' is cyclohexyl and R, R1 as in (a), or Q' is benzyl or 4-fluorobenzyl and R R1 are CH3OCH3 or NH2, OCH3, (d) 1-benzyl-piperidin-4-yl and R, R1 are Z, OCH3, or NH2, OCH7-iso (Z is NH2, CH3, H, CH3O, (CH3)2N or CH3NH), (e) racemic (1-R10-pyrrolidin-2-yl) amino, R10 is CH3 and R, R1 are NH2. OCH3, CH3, OCH3, CH3, EOt, or Et, OEt, or R10 is Et and R, R1 are Z, OCH3, NH2, Z1 (Z1 is ErO, n - or iso-C3H7O), CH3, Z1, Et, OEt, n- or is o-C3H7, OCH3, CH3S, OCH3, or R10 is n-propyl, n-butyl, benzyl or p-fluorobenzyl and R, R1 are NH2, OCH3 or CH3, OCH3, or CH3, OCH3, or R10 is cyclohexylmethyl or allyl and R, R1 are CH3, OCH3. In (I), NR2R3 is (f) the gp. R, R1 are CH3, OCH3 CH3, OEt, (CH3)2N, OCH3 or (CH3)2N, OEt, (g) (1-methylpyrrol-2-yl)methylamino and R1R1 are CH3, OCH3. In (b) NR4R5 is (d) 1,2,3,4-tetrahydroquinoline gp. or anilino and R, R1 are R, R1 =NH2, OCH3, NH2, OEt, CH3, OCH3, CH3S, OCH3 or (CH3)2N, OCH3, (iii)-N(R6) R6, R7 are CH3, H and R, R1=NH2, OCH3, R6, R7 Et, H and R, R1 are NH2, OCH3, CH3, OCH3 or CH3, OEt, or R6R7 are Et, F and R, R1 are CH3, OCH3 or CH3, OEt, (iv) 4-Q-piperazino, Q is phenyl or 4-fluorophenyl and R, R1 are CH3, OCH3, or Q is 2-methoxyphenyl and R, R1 are CH3, OCH3 or NH2, OCH3. (I) are neuroleptics useful for treating psychic disorders. The cpd. with R, R1 = NH2, OCHo and NR2R3-2-(diethylamino) ethylamine has intraperitoneal LD50 in mice 650 mg/kg.
FR7902286A 1978-02-21 1979-01-30 2,4-Di:substd.-pyrimidine-5-carboxamide derivs. - useful as neuroleptics for treating psychic disorders (BE 20.8.79) Granted FR2457286A2 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR7902286A FR2457286A2 (en) 1979-01-30 1979-01-30 2,4-Di:substd.-pyrimidine-5-carboxamide derivs. - useful as neuroleptics for treating psychic disorders (BE 20.8.79)
GR58323A GR66581B (en) 1978-02-21 1979-02-09
US06/011,752 US4250178A (en) 1978-02-21 1979-02-12 Amides derived from carboxyl-5 pyrimidines
IT20206/79A IT1113438B (en) 1978-02-21 1979-02-15 NEW STARCHES DERIVED FROM PYRIMIDIN-5-CARBOXYLIC ACIDS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
CH159879A CH639078A5 (en) 1978-02-21 1979-02-19 AMIDES DERIVED FROM 5-PYRIMIDINIC CARBOXYLIC ACIDS, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM.
LU80937A LU80937A1 (en) 1978-02-21 1979-02-19 NEW AMIDES DERIVED FROM CARBOXYLIC-5-PYRIMIDINIC ACIDS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
ES477852A ES477852A1 (en) 1978-02-21 1979-02-19 Amides derived from carboxyl-5 pyrimidines
CA321,796A CA1096868A (en) 1978-02-21 1979-02-19 Amides derived from carboxyl-5 pyrimidine, the preparation and the therapeutical application thereof
SE7901493A SE446450B (en) 1978-02-21 1979-02-20 AMID DERIVATIVES OF 5-PYRIMIDINE CARBON ACIDS FOR USE IN PSYCHOLOGICAL DISEASES, AND SET FOR THEIR PREPARATION
DE19792906461 DE2906461A1 (en) 1978-02-21 1979-02-20 PYRIMIDINE-5-CARBONIC ACID AMIDE DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING SUCH DERIVATIVES
JP1896279A JPS54130585A (en) 1978-02-21 1979-02-20 Novel amide derived from carboxyy55pyrimidine and its manufacture
AU44392/79A AU526298B2 (en) 1978-02-21 1979-02-20 Amides derived from carboxyl-5 pyrimidines
GB7905890A GB2014984B (en) 1978-02-21 1979-02-20 Pyrimidine-5-carboxamides the preparation and the therapeutical application thereof
NL7901333A NL7901333A (en) 1978-02-21 1979-02-20 NEW 5-PYRIMIDINE CARBONIC ACID AMIDES, THEIR PREPARATION AND THERAPEUTIC USE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7902286A FR2457286A2 (en) 1979-01-30 1979-01-30 2,4-Di:substd.-pyrimidine-5-carboxamide derivs. - useful as neuroleptics for treating psychic disorders (BE 20.8.79)

Publications (2)

Publication Number Publication Date
FR2457286A2 true FR2457286A2 (en) 1980-12-19
FR2457286B2 FR2457286B2 (en) 1981-08-14

Family

ID=9221341

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7902286A Granted FR2457286A2 (en) 1978-02-21 1979-01-30 2,4-Di:substd.-pyrimidine-5-carboxamide derivs. - useful as neuroleptics for treating psychic disorders (BE 20.8.79)

Country Status (1)

Country Link
FR (1) FR2457286A2 (en)

Also Published As

Publication number Publication date
FR2457286B2 (en) 1981-08-14

Similar Documents

Publication Publication Date Title
MX9605128A (en) Neurokinine (tachykinine) antagonists.
CA2009678A1 (en) Pyridazinone, oxadiazinone, thiadiazinone and triazinone cardiotonic agents
PL246224A1 (en) Process for preparing novel derivatives of 1,2,3,5-tetra-hydroimidazo/2,1-b/quinazoline
NZ335542A (en) Benzamidoaldehydes and their use as cysteine protease inhibitors
ES8603885A1 (en) Novel 2-pnenyl-imidazoles, their preparation and drugs containing them.
IL112118A0 (en) Diazabicyclic neurokinin antagonists
HUP9904703A2 (en) Aminothiophene carboxylic acid amides, pharmaceutical compositions containing them and process for their preparation
DK0652871T3 (en) Absorbent article with fastening system that provides dynamic fit of elasticated waistband
HK1018051A1 (en) Diazepino-indoles as phosphodiesterase iv inhibitors
FR2457286A2 (en) 2,4-Di:substd.-pyrimidine-5-carboxamide derivs. - useful as neuroleptics for treating psychic disorders (BE 20.8.79)
FR2417506A1 (en) 2,4-Di:substd.-pyrimidine-5-carboxamide derivs. - useful as neuroleptics for treating psychic disorders (BE 20.8.79)
PL343381A1 (en) Spisulosine compounds having antitumour activity
MX9805700A (en) Chinoline-2-(1h)-ones.
FR2539417B1 (en)
TW366262B (en) Substituted pyridines/pyrimidines, their preparation, and their use as pesticides
AU8445591A (en) N-(mercaptoalkyl)ureas and carbamates
DE69902766T2 (en) N-ARYLOXYETHYLAMINE DERIVATIVES FOR TREATING DEPRESSION
BG106117A (en) Novel 8a- and 9a-15-membered lactams
ATE273284T1 (en) ARYLPHTALAZINE ANTAGONISTS OF EXITATONIC AMINO ACID RECEPTORS
NZ230625A (en) Pentapeptide with inhibitory effect on dna synthesis in regenerating liver and malignant hepatoma
NZ515216A (en) UV-absorbers with an affinity for textile fibres
TWI264304B (en) Methods of treating sepsis
GR3025186T3 (en) The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids
ES8606355A1 (en) New imidazo benzo- or thieno-diazepine derivs.
PT87693A (en) New N-protected peptide derivs. - useful as renin inhibitors for treating hypertension, congestive heart failure and cardiovascular disorders